Deborah handles complex transactions, including mergers and acquisitions, joint ventures, and affiliations, for leading health care providers and investors across the United States. At any given time, Deborah is engaged in leading teams of the firm’s transactional and regulatory lawyers on several large-scale deals. Her clients value her strategic thinking as well as her project management skills, from both a deal closure and cost perspective. Deborah also provides general counseling and strategic planning for both nonprofit and for-profit health care providers. She is consistently recognized by her peers and leading publications for excellence in health care law.
Ms. Daccord is a Member in the firm's Health Law Practice. Her practice focuses on complex transactions, including joint ventures, strategic alliances, and mergers and acquisitions for health industry providers and investors nationwide. She is also a member of the firm's Health Reform Working Group and has served on the Policy Committee.
Her recent health industry merger and acquisition activity includes acquisitions and sales, joint ventures, and strategic affiliations totaling over one billion dollars. Her clients span the health care spectrum, including a Fortune 250 company that is a leading provider of kidney care, and providers of vision cares services, radiology services, hospital development and management services, fertility services, addiction treatment, and behavioral health services. Deborah has extensive project management experience, and provides deal structuring, general counseling, regulatory advice, and strategic planning for both nonprofit and for-profit health care providers.
Deborah is also a certified Pilates instructor.
Education
- Harvard Law School (JD)
- Harvard University (BA, Extension Studies)
Experience
- Represented a Fortune 250 company that is a leading provider of kidney care and the country's largest operator of physician networks in hundreds of acquisitions, sales, and joint ventures nationwide.
- Represented a private equity backed radiology services provider in multiple practice acquisitions.
- Represented multiple clients in developing population health management solutions
Recognition & Awards
- BTI Consulting Group: M&A Client Service All-Star (2021)
- Best Lawyers in America: Health Care Law (2012 – 2022)
- Chambers USA: Massachusetts (Band 1) – Healthcare (2007 – 2018); (Band 2) - Healthcare (2019 – 2021)
- Nightingale’s Healthcare News: Outstanding Healthcare Transaction Lawyer (2009)
- Greater Boston Chamber of Commerce: Boston's Future Leaders (2006)
- Harvard Law School Irving Oberman Memorial Award
Involvement
- Immediate Past Board Chair, Big Sister Association of Greater Boston
- Board of Trustees, Lasell Village
- Founding Member, Women for Whittier
- Member, Women Business Leaders of the U.S. Health Care Industry Foundation
- Board of Visitors, Fenway Health
- Member, American Health Lawyers Association
- Member, Boston Bar Association
Recent Insights
Viewpoints
363 Sales as a Health Care M&A Tool, Part 2 – Pros and Cons for Buyers and Sellers
September 11, 2020 |Blog
363 Sales as a Health Care M&A Tool, Part 1 – Overview
July 28, 2020 |Blog
News & Press
Viewpoints
363 Sales as a Health Care M&A Tool, Part 2 – Pros and Cons for Buyers and Sellers
September 11, 2020 | Blog | By Deborah Daccord, William Kannel, Rachel Irving Pitts, Tim McKeon
As a refresher, a 363 Sale couples a flexible and fast process with ample liability protection for willing buyers. The primary benefit of a 363 Sale is that a buyer can acquire the debtor’s assets free and clear of virtually all liens, claims, and interests burdening the assets and the debtor. And when Section 363 is coupled with the “assumption and assignment” provisions of Section 365 of the Bankruptcy Code, a debtor is able to assign most contracts or leases that a buyer may wish to purchase, including contracts with ironclad anti-assignment language, provided that certain conditions are satisfied. When a target is experiencing severe financial distress, the benefit of acquiring assets “free and clear” is extraordinarily valuable.
363 Sales as a Health Care M&A Tool, Part 1 – Overview
July 28, 2020 | Blog | By Deborah Daccord, William Kannel, Rachel Irving Pitts, Tim McKeon
For those unfamiliar with 363 Sales, a 363 Sale couples a flexible and fast process with ample liability protection for willing buyers. The primary benefit to a 363 Sale is that a buyer can acquire the debtor’s assets free and clear of virtually all liens, claims and encumbrances burdening the assets and the debtor. When a target is experiencing severe financial distress, the benefit of acquiring assets “free and clear of all liens” is extraordinarily valuable.
News & Press
Deborah Daccord Named to Elite List of 2021 BTI M&A Client Service All-Stars
September 09, 2021
Mintz Recognized by Chambers USA 2019
April 26, 2019
Chambers USA 2018 Ranks Mintz Attorneys & Practices
May 03, 2018
Mintz’s Deborah Daccord Named Among “Top Women of Law” by Massachusetts Lawyers Weekly
August 01, 2017
Events
Leading Through a Crisis: COVID-19 Executive Idea Exchange Series
As Companies Working with Senior Populations, How are We Leading?
Webinar
